Applied Therapeutics

OverviewSuggest Edit

Applied Therapeutics is a clinical-stage biopharmaceutical company developing therapies for diabetic complications. Its lead product candidate, AT-001, is an aldose reductase inhibitor (ARI) that is being developed for the treatment of diabetic cardiomyopathy, or DbCM, fatal fibrosis of the heart. The company is also developing AT-007, a central nervous system penetrant ARI, for the treatment of galactosemia.

TypePublic
Founded2017
HQNew York, US
Websiteappliedtherapeutics.com

Latest Updates

Employees (est.) (Dec 2019)11(+10%)
Share Price (Oct 2020)$22.6 (+2%)
Cybersecurity ratingAMore

Key People/Management at Applied Therapeutics

Shoshana Shendelman

Shoshana Shendelman

CEO & Founder
Riccardo Perfetti

Riccardo Perfetti

Chief Medical Officer
Charles Silberstein

Charles Silberstein

Chief Financial Officer
Adam Hansard

Adam Hansard

Chief Commercial Officer
Show more

Applied Therapeutics Office Locations

Applied Therapeutics has an office in New York
New York, US (HQ)
545 5th Ave #1400
Show all (1)

Applied Therapeutics Financials and Metrics

Applied Therapeutics Revenue

USD

Net income (Q2, 2020)

(28.1m)

EBIT (Q2, 2020)

(28.3m)

Market capitalization (23-Oct-2020)

506.6m

Closing stock price (23-Oct-2020)

22.6

Cash (30-Jun-2020)

100.9m

EV

407.6m
Applied Therapeutics's current market capitalization is $506.6 m.
Annual
USDFY, 2017FY, 2018FY, 2019

General and administrative expense

582.0k2.0m13.2m

R&D expense

3.7m11.5m32.4m

Operating expense total

4.3m13.5m45.6m

EBIT

(4.3m)(13.5m)(45.6m)
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

General and administrative expense

1.9m4.2m3.3m5.2m7.5m

R&D expense

6.9m4.3m7.5m7.3m20.8m

Operating expense total

8.7m8.4m10.7m12.5m28.3m

EBIT

(8.7m)(8.4m)(10.7m)(12.5m)(28.3m)
Annual
USDFY, 2017FY, 2018FY, 2019

Cash

3.3m18.7m18.9m

Prepaid Expenses

9.0k1.5m7.3m

Current Assets

3.3m20.2m46.2m

Total Assets

3.3m20.2m48.4m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

14.7m41.1m13.1m92.5m100.9m

Prepaid Expenses

2.2m5.7m4.1m9.4m10.0m

Current Assets

16.9m46.8m37.0m163.7m148.5m

Total Assets

16.9m46.8m37.3m165.9m150.6m
Annual
USDFY, 2017FY, 2018FY, 2019

Net Income

(4.3m)(16.5m)(45.5m)

Accounts Payable

5.8m

Cash From Operating Activities

(3.2m)(11.2m)(36.3m)

Cash From Investing Activities

(20.0m)
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(8.7m)(17.2m)(27.9m)(12.4m)(40.4m)

Accounts Payable

(366.0k)462.0k(1.3m)(7.2m)(3.1m)

Cash From Operating Activities

(7.0m)(16.1m)(23.9m)(18.9m)(34.8m)

Cash From Investing Activities

(19.9m)(41.7m)(17.7m)
USDFY, 2017

Financial Leverage

1.4 x
Show all financial metrics

Applied Therapeutics Operating Metrics

Q1, 2019

Phase II Patients Enrolled

120
Show all operating metrics

Applied Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

Applied Therapeutics Online and Social Media Presence

Embed Graph

Applied Therapeutics News and Updates

Applied Therapeutics to Present Data on AT-001 for Treatment of Diabetic Cardiomyopathy at 56th Annual Meeting of the European Association for the Study of Diabetes

NEW YORK, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present two …

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Applied Therapeutics, Inc. - APLT

NEW YORK, Aug. 18, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Applied Therapeutics, Inc. ("GTT" or the "Company") (NASDAQ: APLT). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The...

Applied Therapeutics Reports Second Quarter 2020 Financial Results

NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the s…

Applied Therapeutics Takes Action Against Fraudulent “Short Report”

On July 1, 2020, a fraudulent “short report” was posted.

Applied Therapeutics Reports Fourth Quarter and Year-end 2019 Financial Results

NEW YORK, March 13, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the …

Applied Therapeutics, Inc. Announces Upsizing and Pricing of Public Offering of 2,741,489 Shares of Common Stock

NEW YORK, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the pricin…
Show more

Applied Therapeutics Blogs

Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference

Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Content Import Wed, 06/03/2020 - 07:01 Applied Therapeutics to Present at the Goldman Sachs 41st Annual Global Healthcare Conference June 3, 2020 at 7:00 AM EDT This …

Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Business Development

Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer and Head of Business Development Content Import Tue, 05/26/2020 - 07:01 Applied Therapeutics Announces Appointment of Dr. Chuck Silberstein, MD, MBA, CFA as Chief Financial Officer …

Applied Therapeutics to Present at the UBS Global Healthcare Conference

Applied Therapeutics to Present at the UBS Global Healthcare Conference Content Import Tue, 05/12/2020 - 07:01 Applied Therapeutics to Present at the UBS Global Healthcare Conference May 12, 2020 at 7:00 AM EDT This release is a backfill from a News Wire …

Applied Therapeutics Reports First Quarter 2020 Financial Results

Applied Therapeutics Reports First Quarter 2020 Financial Results Content Import Mon, 05/11/2020 - 07:01 Applied Therapeutics Reports First Quarter 2020 Financial Results May 11, 2020 at 7:00 AM EDT This release is a backfill from a News Wire Ea…

Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial

AT-007 demonstrated rapid and sustained reduction in toxic galactitol levels with no accompanying increase in galactose Positive trend on MRI outcomes, including indirect measures of edema, neuronal health and brain galactitol levels in AT-007-treated patients 40 mg/kg dose of AT-007 was

Applied Therapeutics Announces IND and Investigator-Initiated Studies of AT-001 in Critical COVID-19 Patients

Applied Therapeutics Announces IND and Investigator-Initiated Studies of AT-001 in Critical COVID-19 Patients Content Import Thu, 04/02/2020 - 07:01 Applied Therapeutics Announces IND and Investigator-Initiated Studies of AT-001 in Critical COVID-19 Patients April 2, 2020 at…
Show more

Applied Therapeutics Frequently Asked Questions

  • When was Applied Therapeutics founded?

    Applied Therapeutics was founded in 2017.

  • Who are Applied Therapeutics key executives?

    Applied Therapeutics's key executives are Shoshana Shendelman, Riccardo Perfetti and Charles Silberstein.

  • How many employees does Applied Therapeutics have?

    Applied Therapeutics has 11 employees.

  • Who are Applied Therapeutics competitors?

    Competitors of Applied Therapeutics include WinSanTor, Abarceo Pharma and REMD Biotherapeutics.

  • Where is Applied Therapeutics headquarters?

    Applied Therapeutics headquarters is located at 545 5th Ave #1400, New York.

  • Where are Applied Therapeutics offices?

    Applied Therapeutics has an office in New York.

  • How many offices does Applied Therapeutics have?

    Applied Therapeutics has 1 office.